MEDP
Medpace Holdings, Inc. · Healthcare
Insiders sold $374.8M of Medpace Holdings, Inc. in the last 12 months and bought none
MEDP over the last year
MEDP after insider buys
3 months after each buy, from the first price a copier could get.
11 buys since 2022 with 3 months of prices.
Congress
Members reported 15 trades in MEDP since 2023.
Every filing
290 insider filings since 2017, newest first
Jesse J Geiger · President
Ashley M. Keating · Director
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
Susan E Burwig · EVP, Operations
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
Robert O. Kraft · Director
Kevin M. Brady · CFO and Treasurer
Stephen P Ewald · GC, Corp. Secy.
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
Kevin M. Brady · CFO and Treasurer
Jesse J Geiger · President
Robert O. Kraft · Director
Stephen P Ewald · GC, Corp. Secy.
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
August J. Troendle · CEO and 10% owner
Medpace Investors, LLC · 10% owner
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.